↓ Skip to main content

Dove Medical Press

Pregabalin for the management of partial epilepsy

Overview of attention for article published in Neuropsychiatric Disease and Treatment, November 2008
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (66th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

twitter
1 X user
wikipedia
1 Wikipedia page

Citations

dimensions_citation
30 Dimensions

Readers on

mendeley
25 Mendeley
Title
Pregabalin for the management of partial epilepsy
Published in
Neuropsychiatric Disease and Treatment, November 2008
DOI 10.2147/ndt.s4716
Pubmed ID
Authors

Philippe Ryvlin, Emilio Perucca, Sylvain Rheims

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 5 20%
Researcher 5 20%
Student > Master 5 20%
Student > Postgraduate 2 8%
Lecturer > Senior Lecturer 1 4%
Other 3 12%
Unknown 4 16%
Readers by discipline Count As %
Medicine and Dentistry 8 32%
Pharmacology, Toxicology and Pharmaceutical Science 4 16%
Agricultural and Biological Sciences 4 16%
Nursing and Health Professions 2 8%
Chemistry 2 8%
Other 2 8%
Unknown 3 12%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 4. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 April 2022.
All research outputs
#7,356,343
of 25,374,647 outputs
Outputs from Neuropsychiatric Disease and Treatment
#948
of 3,132 outputs
Outputs of similar age
#33,291
of 105,270 outputs
Outputs of similar age from Neuropsychiatric Disease and Treatment
#6
of 14 outputs
Altmetric has tracked 25,374,647 research outputs across all sources so far. This one has received more attention than most of these and is in the 69th percentile.
So far Altmetric has tracked 3,132 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.6. This one has gotten more attention than average, scoring higher than 68% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 105,270 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 66% of its contemporaries.
We're also able to compare this research output to 14 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.